…ase (CVD) remains a leading cause of morbidity and mortality in Systemic Lupus Erythematosis (SLE) due to both traditional risk factors and disease-specific…
All extracted diseases
Showing 121–180 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Articles mentioning diseases
23,712 articles · page 321 of 1976…onferred an increased risk for CV events in this Latin-American lupus population. Patients with renal lupus were at higher risk. No a…
…has not previously been reported in SLE. Herein we describe two SLE cases with anti-neurofascin–positive AN and highlight robust re…
…-cell lymphoma was diagnosed, at 50 years old, and treated by a NHL R-CHOP regimen. Also, he had psoriatic relapses and kept losing…
…s To characterize patterns and variability in the management of systemic lupus erythematosus (SLE), including the implementation of a treat to target (T2T) …
…the ACR/EULAR criteria. It may serve as a useful tool for early SLE identification, even when the control patients are ANA-positive…
…Objectives Systemic lupus erythematosus (SLE) is characterized by B cell-driven autoimmunity and an upr…
…Objectives Systemic lupus erythematosus (SLE) is characterised by an activated interferon (IFN) system …
…Objectives The management of SLE varies worldwide. Current SLE treatment goals focus on controlling disease activity and preve…
…total of 339 patients, mostly Caucasian (91.4%), diagnosed with SLE were included in the study ( table 1), with a mean age of 53.2±…
…tives Social determinants of health (SDH) influence outcomes in systemic lupus erythematosus (SLE), yet remain rarely captured in care or research. Because …
…Objectives Systemic Lupus Erythematosus (SLE) predominantly affects females of reproductive age, who fa…